Cargando…
Impact of Fast SARS-CoV-2 Molecular Point-Of-Care Testing on Patients’ Length of Stay in an Emergency Department
The ID NOW COVID-19 system (IDNOW) is a point-of-care test (POCT) providing results within 15 min. We evaluated the impact of IDNOW use on patient length of stay (LOS) in an emergency department (ED). In the ED of Saint-Louis Hospital, Paris, France, adult patients requiring a rapid diagnosis of SAR...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431206/ https://www.ncbi.nlm.nih.gov/pubmed/35730967 http://dx.doi.org/10.1128/spectrum.00636-22 |
_version_ | 1784779988760788992 |
---|---|
author | Baron, Audrey Peyrony, Olivier Salmona, Maud Mahjoub, Nadia Ellouze, Sami Anastassiou, Maud Delaugerre, Constance Fontaine, Jean-Paul Chevret, Sylvie LeGoff, Jerome Feghoul, Linda |
author_facet | Baron, Audrey Peyrony, Olivier Salmona, Maud Mahjoub, Nadia Ellouze, Sami Anastassiou, Maud Delaugerre, Constance Fontaine, Jean-Paul Chevret, Sylvie LeGoff, Jerome Feghoul, Linda |
author_sort | Baron, Audrey |
collection | PubMed |
description | The ID NOW COVID-19 system (IDNOW) is a point-of-care test (POCT) providing results within 15 min. We evaluated the impact of IDNOW use on patient length of stay (LOS) in an emergency department (ED). In the ED of Saint-Louis Hospital, Paris, France, adult patients requiring a rapid diagnosis of SARS-CoV-2 were tested with Cepheid Xpert Xpress SARS-CoV-2 or FilmArray respiratory panel RP2 in the virology laboratory between 18 October and 3 November 2020 (period 1) and with IDNOW between 4 November and 30 November 2020 (period 2). A total of 676 patients participated in the study, 337 during period 1 and 339 during period 2. The median LOS in ED was significantly higher in period 1 than in period 2 (276 versus 208 min, P < 0.0001). More patients spent less than 4 h in the ED in period 2 (61.3%) than in period 1 (38.3%) (P < 0.0001). By univariate analysis, factors associated with ED LOS were hypertension, anosmia/ageusia, number of patients per day, and ID NOW implementation in period 2. By multivariate analysis, the period of testing remained significantly associated with ED LOS. Rapid molecular SARS-CoV-2 POCT was associated with a reduced LOS for patients admitted to an ED. IMPORTANCE During COVID-19 pandemic upsurges, emergency departments had to deal with a massive flow of incoming patients. The need for COVID-19 infection status determination before medical ward admission worsened ED overcrowding. The development of molecular point-of-care testing gave new opportunities for getting faster results of SARS-CoV-2 genome detection 24 h a day. In our study, we show, with a multivariate analysis, that the use of the POCT COVID-19 IDNOW reduced the ED length of stay by 1 h. The rate of patients who waited less than 4 h in the ED increased significantly. Our study highlights the benefit of COVID-19 molecular POCT for preventing ED overcrowding and facilitating bed allocation and SARS-CoV-2-infected patient isolation. |
format | Online Article Text |
id | pubmed-9431206 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Society for Microbiology |
record_format | MEDLINE/PubMed |
spelling | pubmed-94312062022-09-01 Impact of Fast SARS-CoV-2 Molecular Point-Of-Care Testing on Patients’ Length of Stay in an Emergency Department Baron, Audrey Peyrony, Olivier Salmona, Maud Mahjoub, Nadia Ellouze, Sami Anastassiou, Maud Delaugerre, Constance Fontaine, Jean-Paul Chevret, Sylvie LeGoff, Jerome Feghoul, Linda Microbiol Spectr Research Article The ID NOW COVID-19 system (IDNOW) is a point-of-care test (POCT) providing results within 15 min. We evaluated the impact of IDNOW use on patient length of stay (LOS) in an emergency department (ED). In the ED of Saint-Louis Hospital, Paris, France, adult patients requiring a rapid diagnosis of SARS-CoV-2 were tested with Cepheid Xpert Xpress SARS-CoV-2 or FilmArray respiratory panel RP2 in the virology laboratory between 18 October and 3 November 2020 (period 1) and with IDNOW between 4 November and 30 November 2020 (period 2). A total of 676 patients participated in the study, 337 during period 1 and 339 during period 2. The median LOS in ED was significantly higher in period 1 than in period 2 (276 versus 208 min, P < 0.0001). More patients spent less than 4 h in the ED in period 2 (61.3%) than in period 1 (38.3%) (P < 0.0001). By univariate analysis, factors associated with ED LOS were hypertension, anosmia/ageusia, number of patients per day, and ID NOW implementation in period 2. By multivariate analysis, the period of testing remained significantly associated with ED LOS. Rapid molecular SARS-CoV-2 POCT was associated with a reduced LOS for patients admitted to an ED. IMPORTANCE During COVID-19 pandemic upsurges, emergency departments had to deal with a massive flow of incoming patients. The need for COVID-19 infection status determination before medical ward admission worsened ED overcrowding. The development of molecular point-of-care testing gave new opportunities for getting faster results of SARS-CoV-2 genome detection 24 h a day. In our study, we show, with a multivariate analysis, that the use of the POCT COVID-19 IDNOW reduced the ED length of stay by 1 h. The rate of patients who waited less than 4 h in the ED increased significantly. Our study highlights the benefit of COVID-19 molecular POCT for preventing ED overcrowding and facilitating bed allocation and SARS-CoV-2-infected patient isolation. American Society for Microbiology 2022-06-22 /pmc/articles/PMC9431206/ /pubmed/35730967 http://dx.doi.org/10.1128/spectrum.00636-22 Text en Copyright © 2022 Baron et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Article Baron, Audrey Peyrony, Olivier Salmona, Maud Mahjoub, Nadia Ellouze, Sami Anastassiou, Maud Delaugerre, Constance Fontaine, Jean-Paul Chevret, Sylvie LeGoff, Jerome Feghoul, Linda Impact of Fast SARS-CoV-2 Molecular Point-Of-Care Testing on Patients’ Length of Stay in an Emergency Department |
title | Impact of Fast SARS-CoV-2 Molecular Point-Of-Care Testing on Patients’ Length of Stay in an Emergency Department |
title_full | Impact of Fast SARS-CoV-2 Molecular Point-Of-Care Testing on Patients’ Length of Stay in an Emergency Department |
title_fullStr | Impact of Fast SARS-CoV-2 Molecular Point-Of-Care Testing on Patients’ Length of Stay in an Emergency Department |
title_full_unstemmed | Impact of Fast SARS-CoV-2 Molecular Point-Of-Care Testing on Patients’ Length of Stay in an Emergency Department |
title_short | Impact of Fast SARS-CoV-2 Molecular Point-Of-Care Testing on Patients’ Length of Stay in an Emergency Department |
title_sort | impact of fast sars-cov-2 molecular point-of-care testing on patients’ length of stay in an emergency department |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431206/ https://www.ncbi.nlm.nih.gov/pubmed/35730967 http://dx.doi.org/10.1128/spectrum.00636-22 |
work_keys_str_mv | AT baronaudrey impactoffastsarscov2molecularpointofcaretestingonpatientslengthofstayinanemergencydepartment AT peyronyolivier impactoffastsarscov2molecularpointofcaretestingonpatientslengthofstayinanemergencydepartment AT salmonamaud impactoffastsarscov2molecularpointofcaretestingonpatientslengthofstayinanemergencydepartment AT mahjoubnadia impactoffastsarscov2molecularpointofcaretestingonpatientslengthofstayinanemergencydepartment AT ellouzesami impactoffastsarscov2molecularpointofcaretestingonpatientslengthofstayinanemergencydepartment AT anastassioumaud impactoffastsarscov2molecularpointofcaretestingonpatientslengthofstayinanemergencydepartment AT delaugerreconstance impactoffastsarscov2molecularpointofcaretestingonpatientslengthofstayinanemergencydepartment AT fontainejeanpaul impactoffastsarscov2molecularpointofcaretestingonpatientslengthofstayinanemergencydepartment AT chevretsylvie impactoffastsarscov2molecularpointofcaretestingonpatientslengthofstayinanemergencydepartment AT legoffjerome impactoffastsarscov2molecularpointofcaretestingonpatientslengthofstayinanemergencydepartment AT feghoullinda impactoffastsarscov2molecularpointofcaretestingonpatientslengthofstayinanemergencydepartment |